Lidocaine+amylmetacresol+​dichlorobenzylalcohol

Generic name
Lidocaine+amylmetacresol+​dichlorobenzylalcohol
Brand name
ATC Code
R02AA20

Lidocaine+amylmetacresol+​dichlorobenzylalcohol

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Sore throat
  • Oral
    • 12 years up to 18 years
      • 1 lozenge every 2-3 hours, max. 4 per day

      • Duration of treatment:

        Maximum 5 days.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

THROAT PREPARATIONS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Anesthetics, local
R02AD02
Other throat preparations
R02AX01

Reference

  1. Teva B.V, SmPC Trachsil (RVG 118436) 19-05-2021, www.geneesmiddeleninformatiebank.nl

Changes

Therapeutic Drug Monitoring


Overdose